UPDATE 3-AstraZeneca's Recentin fails trial, hurts shares | Reuters
Links shared publicly online about this topic.
- 1,330total visits
UPDATE 3-AstraZeneca's Recentin fails trial, hurts shares | Reuters
* Recentin fails vs Roche's Avastin in late stage study * Analysts say data as expected, Crestor verdict next hurdle * More late stage Recentin trial data due in coming months * AstraZeneca's shares
View full resource at reuters.com
Tags: Cholesterol Medication, Cancer, Colorectal Cancer Medication, Avastin, Crestor, AstraZeneca
Most Recently Shared on March 8, 2010 at 8:44 am By:
AZ's Recentin flunks a head-to-head trial with Avastin, the reigning cancer champ. http://bit.ly/b8WELc
Advertisement
